The Clinical Founder’s Roadmap Trap

Over the years, I’ve worked with a lot of clinical founders, and I’ve noticed the same pattern.

They usually start with a real problem. A painful one. A problem they have seen firsthand with patients, staff, documentation, follow-up, handoffs, or reimbursement. That part is usually strong. In many cases, much stronger than what a purely technical founder starts with.

But then the roadmap starts to drift.

Instead of validating the smallest valuable version of the product, many clinical founders begin designing the full dream state. Every edge case. Every exception. Every specialty nuance. Every workflow variation. Every field they wish existed in the EMR. The roadmap gets bigger before the product gets proven.

That is the trap.

Why it happens

A lot of clinicians are trained perfectionists. That is not a flaw in medicine. In clinical care, details matter. Precision matters. Missing something can have real consequences.

But product building is not clinical decision-making.

In product, perfection too early is expensive. It slows validation, bloats scope, confuses the team, and delays learning. A founder may believe they are reducing risk by making the product more complete. In practice, they are often increasing risk by building too much before knowing what truly matters.

Most clinical founders are not full-time founders. They are still practicing. They operate, see patients, take call, work at hospitals, attend conferences, maintain licenses, complete certifications, and continue medical education. Their schedule is already full before the startup even begins, and that reality affects how products get built.

Decisions happen late at night. Roadmaps get discussed between cases. Requirements are written from memory instead of structured discovery. Validation is replaced with intuition because there is no time to run proper experiments. Technical discussions get postponed because there is no bandwidth to go deep. This often leads to two extremes.

Either the product moves too slowly because the founder cannot spend enough time on it, or the product scope grows too fast because the founder wants to design the perfect system upfront, knowing they will not have time to revisit it later.

Clinical expertise is necessary, but not sufficient

Clinical founders have a huge advantage: they understand the pain deeply.

But that same advantage can become a blind spot.

Many founders see the problem through their own lived clinical lens. They know exactly how it feels in one practice, one specialty, one workflow, one patient population. They know the frustrations, the inefficiencies, the missed follow-ups, the documentation burden.

What they often need help with is zooming out.

A product cannot only reflect one clinician’s mental model. It has to work across roles, workflows, incentives, data constraints, operational realities, and technical limitations. The question is not only, “What would make this easier for me as a clinician?” It is also, “What is the smallest end-to-end solution that creates value for the whole system?”

That distinction matters.

A founder may obsess over a specific note layout while ignoring onboarding friction. They may focus on a nuanced clinical branch while the real bottleneck is referral intake. They may want perfect downstream logic while the product still lacks a simple, reliable way to capture the first signal. They may care deeply about what should happen in the ideal patient journey while the actual product still breaks on handoffs, permissions, or missing data.

That is how teams get stuck in local optimization instead of product progress.

The hidden complexity most clinical founders do not see

Another common issue is underestimating what sits behind a seemingly simple feature.

To a clinician, a feature can sound straightforward:

• Just show the right patients
• Just pull the data from the EMR
• Just summarize the chart
• Just alert us when someone is delayed
• Just generate the billing note

But every “just” in healthcare product development usually hides layers of complexity.

There is workflow complexity: who does what, when, under which role, and with which exception path.

There is data complexity: where the data lives, how structured it is, how often it updates, what is discrete versus scanned, what is missing, and what is unreliable.

There is integration complexity: which system is source of truth, what the API actually exposes, what arrives via HL7 or FHIR, what has to be inferred, and what still requires manual confirmation.

There is compliance complexity: consent, minimum necessary access, audit trails, PHI handling, retention, vendor boundaries, role-based permissions, security reviews, and deployment expectations.

And there is product complexity: what must be configurable, what must be standardized, what can be automated, and what should stay human-in-the-loop.

Clinical founders usually know the clinical nuance. They often need someone else to translate technical, security, compliance, and data architecture realities into language they can actually use to make product decisions.

That translation layer is not optional. In healthcare, it is part of product strategy.

Data is not the same as clinical understanding

This is another trap I see often.

Clinicians look at patient data from the patient standpoint, which makes sense. They think in stories, trajectories, symptoms, risk, history, and care decisions. That is how care is delivered.

But software has to deal with how that reality is stored.

And healthcare data is rarely stored the way clinicians imagine it should be.

The data may live across encounter notes, discrete fields, scanned PDFs, problem lists, claims, referral messages, medication feeds, device data, and custom forms. The same concept may appear in three places with different levels of reliability. A status that feels obvious to a human may not exist as a clean field anywhere. A founder may want “time to treatment,” “patient at risk,” or “care delay reason” surfaced as if those are native data elements, when in reality they often have to be derived, normalized, or manually captured.

That gap between clinical meaning and technical representation is where many products break.

A strong healthcare product team has to bridge both worlds: what clinicians need to know, and what the system can actually know with confidence.

What good process looks like instead

The best clinical founders I’ve worked with still bring their clinical insight, but they pair it with product discipline.

• They focus on the first wedge, not the full vision
• They validate workflow value before polishing edge cases
• They separate must-have from nice-to-have
• They test assumptions early
• They ask how the product works end-to-end, not just at the moment of clinical interaction
• They stay curious about technical and compliance constraints instead of treating them as someone else’s problem
• They bring in people who can help translate across clinical, product, engineering, data, and go-to-market

That is usually the difference between a product that stays stuck in founder intuition and one that becomes deployable, adoptable, and scalable.

My view

The recent story about cardiologist Michał Nedoszytko building PostVisit.ai in seven days shows how much has changed. Clinicians can now prototype and ship faster than ever, and domain expertise has become even more valuable. But building a quick prototype does not mean most clinicians are ready to build production-grade healthcare products on their own.

I enjoy working with clinical founders because they start from real pain and real urgency, often closer to the problem than anyone else. But being close to the problem is not the same as being ready to build the right product. Healthcare products require translation between clinical intuition and product reality. Someone has to control scope, validate assumptions, and connect the idea to technical architecture, data structure, security, compliance, operations, and commercialization.

When that translation is missing, roadmaps grow faster than products. When it is done well, clinical insight turns into something that can actually survive in the real world.